» Articles » PMID: 35850211

Serum Lipids and Risk of Incident Psoriasis: A Prospective Cohort Study from the UK Biobank Study and Mendelian Randomization Analysis

Overview
Publisher Elsevier
Specialty Dermatology
Date 2022 Jul 19
PMID 35850211
Authors
Affiliations
Soon will be listed here.
Abstract

The association between dyslipidemia and psoriasis has been studied widely. However, which individual indicators of serum lipids determine an increasing risk of incident psoriasis is still underappreciated in prospective cohorts. On the basis of UK Biobank, we investigate the causal relationship between four serum lipids and incident psoriasis by Cox proportional hazard model and Mendelian randomization analysis. After adjusting for covariates, high-density lipoprotein deficiency (<1.0 mmol/l for men, <1.3 mmol/l for women) and high triglyceride level (≥1.7 mmol/l) at baseline were associated with 16.6% and 10.6% increased risk of incident psoriasis, respectively. The effects were more pronounced in women, with 16.9 and 19.7% additional risk of psoriasis, respectively. The effects in the younger group (aged <60 years) and obese group in women were also more pronounced. No similar effect was observed in low-density lipoprotein and total cholesterol. Our subsequent Mendelian randomization analysis reinforced the main finding that high-density lipoprotein deficiency and high triglyceride cause incident psoriasis genetically. In conclusion, serum high-density lipoprotein/triglyceride levels predict psoriasis, particularly in women, indicating a distinct role of lipids engaging in the pathogenesis of psoriasis modified by sex. More metabolic-targeted, sex-specific management of psoriasis is suggested in the future.

Citing Articles

Genetically mimicked effects of evinacumab on psoriasis: a drug target Mendelian randomization study.

Yang Z, Xiao W, Zhuang Z, Zhan S, Wang M, Wu Y Asia Pac J Clin Nutr. 2025; 34(1):46-56.

PMID: 39828257 PMC: 11742608. DOI: 10.6133/apjcn.202502_34(1).0004.


Skin Metabolic Signatures of Psoriasis and Psoriasis Concurrent with Metabolic Syndrome.

Yan L, Wang W, Dong M, Wang R, Li C J Inflamm Res. 2025; 18():505-517.

PMID: 39810975 PMC: 11730757. DOI: 10.2147/JIR.S493338.


Causal association between B cell count and psoriasis using two-sample Mendelian randomization.

Zhao Z, Cheng J, Zhu J, Lu S, Lv H, Wu X J Cell Mol Med. 2024; 28(17):e70089.

PMID: 39261978 PMC: 11390492. DOI: 10.1111/jcmm.70089.


Genetic causality and metabolite pathway identifying the relationship of blood metabolites and psoriasis.

Wang Z, Lin X, Chen X, Qin D, Zhang Q, Wang H Skin Res Technol. 2024; 30(7):e13840.

PMID: 38965811 PMC: 11224122. DOI: 10.1111/srt.13840.


A genome-wide cross-trait analysis identifies shared loci and causal relationships of obesity and lipidemic traits with psoriasis.

Wu Y, Huang M, Chen X, Wu J, Li L, Wei J Front Immunol. 2024; 15:1328297.

PMID: 38550599 PMC: 10972863. DOI: 10.3389/fimmu.2024.1328297.